Aymeric Sallin - Jan 2, 2023 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Aymeric Sallin
Stock symbol
SELB
Transactions as of
Jan 2, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 04:00 PM
Previous filing
Jan 5, 2022
Next filing
Nov 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Stock Option (Right to Buy) Award $0 +75K $0.00 75K Jan 2, 2023 Common Stock 75K $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock underlying this award will vest in full on January 2, 2024.